Navigation Links
Bodycad Receives FDA 510K Clearance for Personalized Unicompartmental Knee System
Date:3/29/2017

QUEBEC CITY, March 29, 2017 /PRNewswire/ -- Bodycad announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee System, enabling the commercial launch of this truly personalized orthopaedic restoration. Bodycad is the first Canadian company to receive FDA clearance for a joint reconstruction implant system.

Bodycad's revolutionary Unicompartmental Knee System is designed to optimize personalized restoration of the patient's unique anatomical features and kinematics. The system is based on proprietary 3D rendering of medical images of the patient's anatomy. The restoration is delivered as a "procedure in a box" that completely revolutionizes the way orthopaedic implant and instrument applications are delivered and utilized in the operating room environment.

Continue Reading
The Bodycad Unicompartmental Knee System enables an orthopaedic restoration that is personalized to the patient's unique anatomical requirements
The Bodycad Unicompartmental Knee System enables an orthopaedic restoration that is personalized to the patient's unique anatomical requirements

"The personalized restoration is created only after proper acquisition of data from the patient on an individualized level," says Etienne Belzile, MD, orthopaedic surgeon and assistant professor at Laval University. "The benefit of personalized restoration is the possibility of a better fit to the individual, less trauma to the soft tissue, and potentially a faster recovery overall."

Bodycad uses proprietary imaging algorithms to rapidly produce a precise 3D image of the patient's knee. Its suite of Personalized Restoration Software enables a seamless integration of the image to implant process called the PREP (personalized restoration evaluation process). The efficient and rapid process is designed to increase patient satisfaction while improving economic quality metrics.

"Our proprietary software is based on 20 years of research in anthropometric data and is the first CAD/CAM software specifically developed for the personalization of orthopaedic implant and instrument design," says Jean Robichaud, founder and CEO of Bodycad. "I am delighted to have FDA clearance to bring this important technological advancement to market. Our goal is to transform the way surgeons, patients and insurers think about the potential of mass customization to optimize patient care."

About Bodycad

Bodycad is a Quebec City-based developer and manufacturer of personalized orthopaedics. Its personalized restorations offer patients a high level of conformity to their unique anatomy, with the potential for greater comfort, fit and durability that make the pursuit of orthopaedic perfection possible. Learn more at www.bodycad.com.

Contact

Andy McLeod
2035 rue du Haut-Bord
Quebec, Quebec, Canada
G1N 4R7
(418) 527.1388
info@bodycad.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bodycad-receives-fda-510k-clearance-for-personalized-unicompartmental-knee-system-300431403.html


'/>"/>
SOURCE Bodycad
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Bodycad Awarded Key US Patents for Improving Accuracy, Reproducibility and Speed for 3D Imaging in Orthopaedic Applications
2. IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit
3. Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
6. BioElectronics Receives Working Capital Infusion
7. Inostics Blood-based Mutation Testing Receives CLIA Certification
8. Breathe Technologies Sleep System Receives FDA Clearance
9. Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants
10. Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com
11. Prime Therapeutics specialty pharmacy receives URAC accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... ... September 18, 2019 , ... NDA Partners Chairman ... well-respected preclinical drug development expert with a focus in the cardiovascular and metabolic ... to joining NDA Partners, Dr. Hoffmann served as Executive Director of Preclinical Safety ...
(Date:9/17/2019)... New Zealand (PRWEB) , ... September 17, 2019 , ... ... in in Fast Company’s 2019 Innovation by Design Awards Students category. , It was ... at the Auckland Bioengineering Institute. , Muss-Bits is comprised of two parts. A “sensor ...
(Date:9/17/2019)... ... 2019 , ... Scientists writing in a 2017 issue of ... progressive destruction of joint cartilage in osteoarthritis are “on the close horizon.” ... orthopedic surgeon Alejandro Badia, MD , founder and chief medical officer of ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... 17, 2019 , ... Caravan Health is seeking ... the country, the company announced today. High-performing community health systems and providers can ... cost efficiency. This opportunity is open to those new to value-based Medicare payment ...
(Date:9/17/2019)... PASO ROBLES, Calif. (PRWEB) , ... September 17, ... ... Pismo Beach , CA, recently announced that he has been certified by the ... Botox in dentistry is used to correct a wide range of orofacial conditions ...
(Date:9/17/2019)... BOSTON (PRWEB) , ... September 17, 2019 , ... ... Participation (CISCRP) is pleased to announce the release of the third edition of ... a comprehensive, easy-to-read guide for patients, caregivers and families to navigate the clinical ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... detection and treatment of infectious diseases at its annual Congress (WMIC) recently ... detection of residual HIV infected cell persistence and the development of pathogen-specific ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful ... coronary artery disease as he hopes to prevent anyone from having it and to ... author John Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to ...
Breaking Medicine News(10 mins):